present
studi
aim
investig
whether
serum
concentr
serum
amyloid
saa
measur
surfaceenhanc
laser
desorptionion
seldi
proteinchip
technolog
elisa
use
differenti
patient
sever
acut
respiratori
syndrom
sar
nonsar
patient
suspect
case
sar
outbreak
period
recent
report
kang
et
al
mean
intens
protein
peak
mz
identifi
seldi
proteinchip
technolog
sar
patient
group
time
greater
intens
correspond
peak
control
patient
group
seldi
peak
observ
previous
anoth
proteom
studi
similar
experiment
condit
identifi
saa
recent
studi
yip
et
al
intens
seldi
peak
mz
identifi
saa
significantli
higher
sar
patient
group
control
group
similar
increas
peak
also
found
pediatr
patient
sar
studi
suggest
saa
use
diagnosi
sar
studi
control
case
either
healthi
person
patient
viral
infect
clinic
unfortun
degre
similar
symptom
sar
control
group
particip
time
point
blood
collect
consid
studi
perspect
infecti
diseas
diagnosi
tri
differenti
healthi
person
infect
patient
rather
tri
identifi
diseas
caus
symptom
patient
present
similar
symptom
bear
mind
issu
recent
attempt
profil
compar
serum
proteom
adult
patient
earli
stage
sar
infect
adult
nonsar
patient
suspect
case
sar
outbreak
period
found
specif
seldi
peak
sera
adult
sar
patient
howev
peak
correspond
saa
identifi
sarsspecif
featur
led
us
question
whether
saa
use
biomark
diagnosi
sar
studi
nonsar
patient
symptom
similar
sar
patient
admiss
admit
hospit
sar
patient
later
shown
neg
sar
coronaviru
cov
infect
antisarscov
antibodi
serolog
test
least
week
onset
symptom
saa
concentr
serum
sampl
nonsar
case
sar
case
remain
seldi
studi
determin
antisaa
elisa
accord
manufactur
instruct
biosourc
intern
use
proteinchip
array
also
call
ph
bind
buffer
tolson
et
al
show
peak
mz
mz
mz
fulllength
saa
desarginin
desargininedesserin
variant
terminu
respect
seldi
dataset
obtain
proteinchip
type
bind
condit
seldi
peak
similar
mz
valu
mean
valu
mz
mz
mz
spearman
rank
correl
analysi
show
normal
intens
peak
correl
highli
serum
concentr
valu
obtain
elisa
correl
coeffici
p
valu
tabl
high
correl
strongli
suggest
seldi
peak
mz
mz
mz
fulllength
saa
desarginin
desargininedesserin
variant
terminu
contrast
previou
seldi
studi
normal
intens
peak
significantli
lower
adult
sar
patient
instead
higher
adult
nonsar
patient
p
valu
tabl
analyz
elisa
data
found
serum
saa
concentr
greatli
increas
sar
nonsar
patient
group
mean
serum
saa
concentr
sar
nonsar
patient
group
higher
upper
limit
refer
interv
mgl
respect
consist
seldi
data
serum
saa
concentr
significantli
lower
sar
patient
group
p
tabl
result
seldi
proteinchip
assay
elisa
indic
serum
saa
use
differenti
sar
patient
nonsar
patient
suspect
case
sar
outbreak
period
serum
saa
increas
sar
patient
howev
could
exclud
possibl
could
use
combin
serum
marker
develop
classif
model
sar
diagnosi
serum
saa
acutephas
reactant
shown
increas
variou
type
viral
bacteri
infect
regardless
type
infect
serum
saa
concentr
increas
mgl
degre
increas
may
reflect
sever
ill
indic
caus
sar
patient
group
found
saa
peak
serum
concentr
correl
significantli
serum
creactiv
protein
concentr
tabl
infecti
diseas
suggest
increas
serum
saa
caus
mainli
inflammatori
respons
sar
infect
conclus
data
seldi
proteinchip
profil
studi
elisa
studi
support
content
increas
serum
saa
indic
sar
contrast
result
strongli
suggest
serum
saa
concentr
use
differenti
sar
patient
nonsar
patient
suspect
case
sar
outbreak
period
